Efficient Neutralization of SARS-CoV-2 Omicron and Other VOCs by a Broad Spectrum Antibody 8G3
Hang Ma(Ministry of Education of the People's Republic of China), Jianwei Zhu(Quzhou University), Yueqing Xie(Bechtel (United States)), Aleksandra Drelich(The University of Texas Medical Branch at Galveston), Huifang Zong(Shanghai Jiao Tong University), Lei Han(Hanpoong Pharm (South Korea)), J Gilly, Haoneng Tang(Ministry of Education of the People's Republic of China), Vivian Tat(The University of Texas Medical Branch at Galveston), Mingyuan Wu(Shanghai Jiao Tong University), Yanlin Bian(Ministry of Education of the People's Republic of China), Yali Yue(Ministry of Education of the People's Republic of China), Chien‐Te K. Tseng(The University of Texas Medical Branch at Galveston), Hua Jiang(Inserm), Zhenyu Wang(Henan Provincial People's Hospital), Hua Chen, Yi Chen(Zhengzhou University), Ziqi Wang(Zhengzhou University), Yang He, Li Yang(Sichuan University), Junjun Liu(Ministry of Education of the People's Republic of China), Tao Sun(Shanghai First People's Hospital), Yunji Liao(Ministry of Education of the People's Republic of China), Shusheng Wang(Soochow University), Baohong Zhang(Shanghai Jiao Tong University), Jason Hsu(The University of Texas Medical Branch at Galveston), Wenbo Xu(Shenyang Institute of Automation), Yong Ke(Ministry of Education of the People's Republic of China), Haiyang Yin(Ministry of Education of the People's Republic of China), Yunsong Chang, Yunsheng Yuan(Shanghai Jiao Tong University), Xiaoxiao Zhang(Shanghai University of Traditional Chinese Medicine), En Zhang(Ningbo University), Lei Wang(Shanghai Jiao Tong University), Xiaoju Zhang(Henan University)
Cited by 6
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k